VA New York Harbor Healthcare System

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, VA New York Harbor Healthcare System sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 7 completed top decile by trial count

VA New York Harbor Healthcare System: 9 sponsored US clinical trials, none currently recruiting.

VA New York Harbor Healthcare System sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. The most-studied condition in this pipeline is Prosthesis User, with 2 trials.

Top-decile sponsor footprint

VA New York Harbor Healthcare System ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

How the VA New York Harbor Healthcare System archive is shaped

9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Prosthesis User (2 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

VA New York Harbor Healthcare System: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

VA New York Harbor Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share VA New York Harbor Healthcare System4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi company10xBio22nd Century Group23andMe3-C Institute for Social Development
VA New York Harbor Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

VA New York Harbor Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

What to do with this VA New York Harbor Healthcare System page

9 registered trials is a research-attention snapshot, not an endorsement of VA New York Harbor Healthcare System or any single study.

  • None of VA New York Harbor Healthcare System's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Prosthesis User is the condition VA New York Harbor Healthcare System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prosthesis User trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

VA New York Harbor Healthcare System pipeline card: 9 registered trials from official public datasets.Report a data error.